| # | Title | Journal | Year | Citations |
|---|
| 1 | Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides | Regulatory Peptides | 1999 | 1,135 |
| 2 | Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers | Regulatory Peptides | 1984 | 702 |
| 3 | Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides | Regulatory Peptides | 1986 | 610 |
| 4 | The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism | Regulatory Peptides | 2001 | 547 |
| 5 | Leptin is a potent stimulator of bone growth in ob/ob mice | Regulatory Peptides | 2000 | 445 |
| 6 | Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes | Regulatory Peptides | 2004 | 399 |
| 7 | Reactive oxygen species as mediators of angiotensin II signaling | Regulatory Peptides | 2000 | 372 |
| 8 | Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research | Regulatory Peptides | 1992 | 365 |
| 9 | Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects | Regulatory Peptides | 2003 | 360 |
| 10 | Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide | Regulatory Peptides | 1996 | 356 |
| 11 | Angiotensin-(1–7): an update | Regulatory Peptides | 2000 | 353 |
| 12 | The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas | Regulatory Peptides | 2002 | 353 |
| 13 | Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus | Regulatory Peptides | 1982 | 348 |
| 14 | Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium | Regulatory Peptides | 2004 | 338 |
| 15 | Vasopressinergic regulation of the hypothalamic–pituitary–adrenal axis: implications for stress adaptation | Regulatory Peptides | 2000 | 331 |
| 16 | A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control | Regulatory Peptides | 2001 | 319 |
| 17 | Two molecular forms of Peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1–36 and PYY 3–36 | Regulatory Peptides | 1994 | 315 |
| 18 | Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects | Regulatory Peptides | 1986 | 306 |
| 19 | Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV | Regulatory Peptides | 1993 | 305 |
| 20 | Opioid receptors in the gastrointestinal tract | Regulatory Peptides | 2009 | 303 |
| 21 | Levels of angiotensin and molecular biology of the tissue renin angiotensin systems | Regulatory Peptides | 1993 | 294 |
| 22 | A selective orexin-1 receptor antagonist reduces food consumption in male and female rats | Regulatory Peptides | 2000 | 288 |
| 23 | GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine | Regulatory Peptides | 2003 | 284 |
| 24 | The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7–37) in normal and diabetic subjects | Regulatory Peptides | 1994 | 281 |
| 25 | The effects of tachykinins on inflammatory and immune cells | Regulatory Peptides | 1997 | 270 |
| 26 | Inhibitory effect of ghrelin on food intake is mediated by the corticotropin-releasing factor system in neonatal chicks | Regulatory Peptides | 2005 | 266 |
| 27 | Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig | Regulatory Peptides | 1985 | 261 |
| 28 | Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia–reperfusion injury in rat heart | Regulatory Peptides | 2008 | 252 |
| 29 | Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells | Regulatory Peptides | 2004 | 251 |
| 30 | The vagus nerve, food intake and obesity | Regulatory Peptides | 2008 | 249 |
| 31 | Protein distribution of the orexin-2 receptor in the rat central nervous system | Regulatory Peptides | 2002 | 244 |
| 32 | Discovery of a distinct binding site for angiotensin II (3–8), a putative angiotensin IV receptor | Regulatory Peptides | 1992 | 240 |
| 33 | Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells | Regulatory Peptides | 2005 | 239 |
| 34 | Brain oxytocin inhibits the (re)activity of the hypothalamo–pituitary–adrenal axis in male rats: involvement of hypothalamic and limbic brain regions | Regulatory Peptides | 2000 | 233 |
| 35 | Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor | Regulatory Peptides | 2001 | 224 |
| 36 | Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide | Regulatory Peptides | 1996 | 220 |
| 37 | Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior | Regulatory Peptides | 1997 | 218 |
| 38 | Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats | Regulatory Peptides | 1995 | 210 |
| 39 | Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A | Regulatory Peptides | 1986 | 209 |
| 40 | Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin | Regulatory Peptides | 1993 | 208 |
| 41 | Angiotensin II in central nervous system physiology | Regulatory Peptides | 1998 | 208 |
| 42 | Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes | Regulatory Peptides | 2008 | 208 |
| 43 | Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum | Regulatory Peptides | 1983 | 202 |
| 44 | Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7–36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides | Regulatory Peptides | 1995 | 202 |
| 45 | Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans | Regulatory Peptides | 2008 | 199 |
| 46 | Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding | Regulatory Peptides | 2005 | 198 |
| 47 | Gastric Inhibitory Polypeptide: the neglected incretin revisited | Regulatory Peptides | 2002 | 197 |
| 48 | What do we know about the secretion and degradation of incretin hormones? | Regulatory Peptides | 2005 | 197 |
| 49 | The primary structure of porcine glicentin (proglucagon) | Regulatory Peptides | 1981 | 195 |
| 50 | Short communication | Regulatory Peptides | 1998 | 194 |
